Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,1412,160 of 20,252 grants

Active RESEARCH CENTERS
Core 1: Planning and Evaluation
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

The goals of the Planning and Evaluation Core (PEC) are to monitor, evaluate, and assess the progress of our U54 Partnerships in meeting its milestones, objectives, and goals. The...

Active OTHER RESEARCH-RELATED
Rwanda CASCADE Clinical Trials Site for cervical cancer prevention
NATIONAL CANCER INSTITUTE Research for Development Rwanda 2023 – 2027

ABSTRACT Cervical cancer is a highly preventable malignancy caused by high-risk human papillomavirus (hrHPV) but is not fully prevented, especially in low- and middle-income countr...

$3.51M
USD
Active RESEARCH CENTERS
Full Project 2
NATIONAL CANCER INSTITUTE University of California Riverside United States 2023 – 2028

PIN1 is a cis-trans prolyl isomerase that controls proline-mediated phosphorylation signaling events that is overexpressed both in pancreatic cancer cells and cancer-associated fib...

Active RESEARCH CENTERS
Core 2: Research Education
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

Cancer drugs in the United States are almost exclusively developed by, tested in, and optimized for European- Americans. Disparities in U.S. drug development are the result of long...

Active RESEARCH CENTERS
Pilot-Project 1
NATIONAL CANCER INSTITUTE University of California Riverside United States 2023 – 2028

University of California, Riverside (UCR) has never implemented a therapeutic trial. Building therapeutic trial capacity at UCR was our biggest challenge – and the biggest failure...

Active RESEARCH CENTERS
Core 3: Outreach
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

Our U54 Outreach Core will facilitate the successful translation, implementation, and dissemination of research findings developed by U54 investigators. We build on the community r...

Active RESEARCH CENTERS
Planning & Evaluation
NATIONAL CANCER INSTITUTE University of California Riverside United States 2023 – 2028

The goals of the Planning and Evaluation Core (PEC) are to monitor, evaluate, and assess the progress of our U54 Partnerships in meeting its milestones, objectives, and goals. The...

Active RESEARCH CENTERS
Research Education
NATIONAL CANCER INSTITUTE University of California Riverside United States 2023 – 2028

Cancer drugs in the United States are almost exclusively developed by, tested in, and optimized for European- Americans. Disparities in U.S. drug development are the result of long...

Active RESEARCH CENTERS
Outreach
NATIONAL CANCER INSTITUTE University of California Riverside United States 2023 – 2028

Our U54 Outreach Core will facilitate the successful translation, implementation, and dissemination of research findings developed by U54 investigators. We build on the community r...

Active NON-SBIR/STTR RPGS
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
NATIONAL CANCER INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Breast cancer brain metastasis (BCBM) is a major clinical challenge due to their poor response to therapeutic options. Although the survival rate of breast...

$4.75M
USD
Active NON-SBIR/STTR RPGS
UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2028

PROJECT SUMMARY: Children diagnosed with acute myeloid leukemia (AML) continue to have an overall poor outcome with rates of relapse that approach 40%. Relapsed disease is particul...

$3.96M
USD
Active OTHER RESEARCH-RELATED
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY Liquid biopsy is a clinical test that involves the analysis of various biomarkers present in the blood or other types of body fluids. It enables the detection of ca...

$7.52M
USD
Active NON-SBIR/STTR RPGS
Increasing Participation in NCI-Funded Clinical Trials at Winship Cancer Institute
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT I have devoted my career to the improvement of outcomes for patients with lymphoma and have utilized my expertise to improve clinical trial conduct at my h...

$1.57M
USD
Active NON-SBIR/STTR RPGS
Developing a Trustworthy Multilevel Intervention to Improve Equity in Lung Cancer Screening
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2023 – 2026

Modified Project Summary/Abstract Section PROJECT SUMMARY/ABSTRACT Lung cancer screening using low-dose computed tomography significantly reduces lung cancer mortality, the leading...

$2.03M
USD
Active NON-SBIR/STTR RPGS
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2023 – 2028

PROJECT SUMMARY Cachexia is a devastating complication of cancers and other inflammatory conditions that is defined by rapid and persistent loss of fat and muscle that is not rever...

$3.61M
USD
Completed SBIR-STTR RPGS
Comprehensive Assessment of Cancer Theranostics Response
NATIONAL CANCER INSTITUTE Aiq Solutions, Inc United States 2023 – 2025

Project Summary Theranostics combines molecular targeted diagnostic and therapeutic radionuclides for imaging and ther- apy in advanced malignancies, with a projected US market of...

$11.04M
USD
Active OTHER RESEARCH-RELATED
Characterizing women living with HIV at cervical cancer diagnosis in Rwanda: Mentored Research under the Rwanda CASCADE Clinical Trials Site
NATIONAL CANCER INSTITUTE Research for Development Rwanda 2023 – 2027

Title: Characterizing women living with HIV at cervical cancer diagnosis in Rwanda: Mentored Research under the Rwanda CASCADE Clinical Trials Site ABSTRACT This application is bei...

$1.24M
USD
Active NON-SBIR/STTR RPGS
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
NATIONAL CANCER INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Breast cancer brain metastasis (BCBM) is a major clinical challenge due to their poor response to therapeutic options. Although the survival rate of breast...

$926.9K
USD
Active NON-SBIR/STTR RPGS
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Melanoma (MEL) is a model malignancy for studying the mechanisms of cancer immunotherapy. Antibodies that block negative regulators of T cell function, ter...

$4.31M
USD
Active NON-SBIR/STTR RPGS
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

PROJECT SUMMARY: Background: Acute myeloid leukemia (AML) is one of the most aggressive types of hematopoietic malignancies with various genetic alterations. Ten-Eleven Translocati...

$6.84M
USD